| CERTIFICATE OF DETERMINATION OF MEMBER | |
| CITATION: | Schellack v Jarvie Engineering Pty Ltd [2024] NSWPIC 665 |
| APPLICANT: | Glenn Schellack |
| RESPONDENT: | Jarvie Engineering Pty Ltd |
| MEMBER: | Fiona Seaton |
| DATE OF DECISION: | 3 December 2024 14 February 2025 |
| CATCHWORDS: | WORKERS COMPENSATION - Workers Compensation Act 1987; disputed right shoulder disease injury and entitlement to weekly benefits and medical and related expenses; Held – the applicant suffered an aggravation, acceleration, exacerbation or deterioration of a disease process in the right shoulder within the meaning of section 4(b)(ii) arising out of his employment with the respondent deemed to have occurred on 9 August 2023; the applicant had no current work capacity between 9 August 2023 and 12 February 2024 as a result of the injury; the respondent is to pay the applicant weekly benefits compensation and reasonably necessary medical and related treatment as a result of the injury. |
| DETERMINATIONS MADE: | The Commission determines: 1. The Application to Resolve a Dispute is amended to include the deemed date of injury 9 August 2023. 2. The applicant suffered an aggravation, acceleration, exacerbation or deterioration of a disease process in his right shoulder in the course of his employment with the respondent with deemed date of injury 9 August 2023 pursuant to s 4(b)(ii) of the Workers Compensation Act 1987 (1987 Act). 3. The applicant had no current work capacity from 9 August 2023 to 12 February 2024 and is entitled to weekly compensation in that period pursuant to ss 36 and 37 of the 1987 Act. 4. The applicant is entitled to payment of reasonably necessary medical, hospital and related expenses arising from the right shoulder injury with deemed date of injury 9 August 2023 including the cost of surgery on 9 August 2023 pursuant to s 60 of the 1987 Act. The Commission orders: 5. The respondent is to pay the applicant weekly compensation at the pre-injury average weekly earnings rate of $1,537.99 subject to indexation as follows; (a) for the period 9 August 2023 to 30 September 2023 at $1,537.99 x 95%, being $1,461.09, pursuant to s 36(1) of the 1987 Act; (b) for the period 1 October 2023 to 8 November 2023 at $1,537.99 x 1.0237, or $1,574.44 rounded to $1,570.00 x 95%, being $1,491.50 pursuant to s 36(1) of the 1987 Act, and (c) for the period 9 November 2023 to 12 February 2024 at $1,574.44 rounded to $1,570.00 x 80%, being $1,256.00 pursuant to s 37(1) of the 1987 Act. 6. The parties have 14 days liberty to apply with respect to the calculation of indexation of the weekly compensation amount referred to above. 7. The respondent is to pay the reasonably necessary medical, hospital and related expenses arising from the applicant’s right shoulder injury with deemed date of injury 9 August 2023 including the cost of surgery on 9 August 2023 pursuant to s 60 of the 1987 Act at the State Insurance Regulatory Authority gazetted rates. A brief statement is attached setting out the Commission’s reasons for the determination. |
Continue reading Schellack v Jarvie Engineering Pty Ltd
Sign in free to access the full text
- AGLC
- Schellack v Jarvie Engineering Pty Ltd [2024] NSWPIC 665
- Case
- [2024] NSWPIC 665
- Decision Date
CaseChat Overview and Summary
The court was tasked with determining whether Schellack's shoulder condition met the criteria for an aggravation, acceleration, exacerbation, or deterioration of a disease process, and whether this condition arose out of his employment. The court had to examine the medical evidence and the factual circumstances surrounding the progression of Schellack's shoulder condition to establish if there was a causal link between his employment activities and the deterioration of his condition. Additionally, the court needed to assess the period during which Schellack was incapable of working due to the injury and whether the employer was liable for compensation during that period.
In its decision, the court found that Schellack had suffered an aggravation, acceleration, exacerbation, or deterioration of a disease process in the right shoulder arising out of his employment with Jarvie Engineering, deemed to have occurred on 9 August 2023. The court accepted that Schellack had no current work capacity between 9 August 2023 and 12 February 2024 due to the injury. The court held that Jarvie Engineering was responsible for paying Schellack weekly benefits compensation and reasonably necessary medical and related treatment costs as a result of the injury. The court's determination was based on a comprehensive analysis of the medical evidence and the specific work-related factors contributing to the aggravation of Schellack's shoulder condition.
Jarvie Engineering Pty Ltd was ordered to pay Schellack weekly benefits compensation and reasonably necessary medical and related treatment costs for the period from 9 August 2023 to 12 February 2024, inclusive. The court directed that the employer would be responsible for these payments, acknowledging the causal link between Schellack's employment activities and the aggravation of his shoulder condition.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.